Table 2.
Conventional Assessment/Molecular Assessment | Pure TCMR | Pure ABMR | Mixed | No Rejection | Total |
---|---|---|---|---|---|
Pure TCMR | 34a | 1 | 8 | 24 | 67 |
Pure ABMR | 5 | 59a | 5 | 41 | 110 |
Mixed | 4 | 16 | 6a | 2 | 28 |
Borderline | 17 | 8 | 5 | 59 | 89 |
Transplant glomerulopathy | 0 | 12 | 0 | 15 | 27 |
No rejectionb | 16 | 28 | 4 | 334a | 382 |
Total | 76 | 124 | 28 | 475 | 703 |
Potential reclassification by molecular scores | 42 | 64 | 22 | 126 | 254 |
The principal areas of agreement between conventional and molecular diagnoses.
Diagnoses include PVN, GN, atrophy fibrosis of unknown significance, no major abnormalities, transplant glomerulopathy, others, and relatively normal.